Filing metadata

Accession number
0000950170-24-034165
Form type
Form 3
Filer
Fulcrum Therapeutics, Inc.
CIK
CIK 1680581
Filed
Mar 20, 2024
Reporting period
Mar 18, 2024
Description
Initial ownership

Explore SEC Filings Hub